Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer: The t-BRCA Study

NCT06274541 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT06274541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06274541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer: The t-BRCA Study
Lead sponsor
Cancer Trials Ireland
Phase
Observational
Overall status
Completed
Start date
March 22, 2019
Completion date
March 12, 2026
Enrollment
200 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioid carcinoma ovary, fallopian tube cancer, primary peritoneal carcinoma, serous ovarian tumor